Month: August 2021

Rogers, Arkansas , Aug. 02, 2021 (GLOBE NEWSWIRE) — America’s Car-Mart, one of the largest publicly-held automotive retailers in the “Integrated Auto Sales and Finance” segment of the used car market, is commemorating its 40th year in business. In 1981, Car-Mart set out a vision to help credit-challenged customers find a vehicle that makes a difference in their lives. For 40 years, the Company has provided transportation solutions and legendary service to customers and local communities. In August 1981, founder Bill Fleeman opened the first Car-Mart in a converted Dog n’ Suds fast food operation in Rogers, Arkansas. That store featured quality, used vehicles and flexible financing. Mr. Fleeman’s purpose was to provide a good value for the customers’ money. Now with over 2,000 associates, 151 dealerships in 12 states and over...

CENTREVILLE, Va., Aug. 02, 2021 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) has won a prime position on the General Services Administration‘s (GSA) multiple-award ASTRO indefinite-delivery/indefinite-quantity (ID/IQ) contract. The contract has a potential value in the multi-billions with no defined ceiling value and a 10-year ordering period. The new contract is being administered through GSA’s Federal Systems Integration and Management Center (FEDSIM). It focuses on providing innovative, future technology, products, solutions, and capabilities to the Department of Defense across the all-domain battlespace. Parsons was selected for six pools: ground, space, development and integration, research, support, and training. “Parsons’ breadth of combat-proven all-domain solutions, artificial intelligence and machine learning technology,...

WALTHAM, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported key business updates and financial results for the quarter ended June 30, 2021. Roluperidone Update Following the completion of the open-label portion of the Phase 3 trial with roluperidone in schizophrenia and the Type C meeting with the U.S. Food and Drug Administration (FDA), the Company continues to work towards the submission of a New Drug Application (NDA) in the first half of 2022. On June 29, 2021, the Company completed the enrollment of 48 subjects in a pivotal bioequivalence study with roluperidone in healthy volunteers. The objective of this study is to compare the formulations employed...

Ms. Lynch will lead ongoing building and implementation of ReWalk’s market access and reimbursement programs MARLBOROUGH, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced Jeannine Lynch will join the Company on August 31, 2021, as Vice President of Strategy and Market Access. Ms. Lynch will focus on completing the building and implementation of ReWalk’s market access and reimbursement programs. Ms. Lynch will report to ReWalk CEO, Larry Jasinski. She will also be part of the management team responsible for overseeing planning and implementation of all company business strategy and policies. “We have been the worldwide leader in building payment pathways and coverage for...

Company to ramp up marketing efforts for Provista’s automated capabilities for COVID-19 PCR testing, variant identification, and neutralizing antibody testing NEW YORK, NY, and TEL AVIV, ISRAEL, Aug. 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has made the final payment of $1.25 million to complete its $10 million acquisition of Provista Diagnostics, Inc. Provista is a medical diagnostics company based in Alpharetta, Georgia that owns the intellectual property rights to the proprietary breast cancer blood test, Videssa®, and has a diagnostic testing laboratory currently performing COVID-19 PCR testing, primarily for the medical and entertainment industries.  Over $50 million in research and development...

Results for the Second Quarter of 2021Net income of $10.3 million, or $0.44 per common unit Adjusted EBITDA of $12.7 million and distributable cash flow of $11.2 million Quarterly cash distribution of $0.12 per unit Distribution coverage ratio of 3.95x, LTM distribution coverage ratio of 4.01xOMAHA, Neb., Aug. 02, 2021 (GLOBE NEWSWIRE) — Green Plains Partners LP (NASDAQ:GPP) today announced financial and operating results for the second quarter of 2021. Net income attributable to the partnership was $10.3 million, or $0.44 per common unit, for the second quarter of 2021 compared with net income of $10.2 million, or $0.43 per common unit, for the same period in 2020. The partnership also reported adjusted EBITDA of $12.7 million and distributable cash flow of $11.2 million for the second quarter of 2021, compared with adjusted...

BEIJING, Aug. 02, 2021 (GLOBE NEWSWIRE) — Kingsoft Cloud Holdings Limited (“Kingsoft Cloud” or the “Company”) (NASDAQ: KC), a leading independent cloud service provider in China, announced that the Company made a major strategic move in its Enterprise Cloud Services (“ECS”) business by entering into a definitive agreement to acquire controlling interests in Camelot Employee Scheme Inc. (“Camelot”). The proposed transaction is expected to bring significant synergies to the Company, in particular:By integrating Camelot’s nationwide project execution capacities and resources across major cities in China, including Beijing, Wuhan, Nanjing, Shanghai, among others, the Company expects to further accelerate and enhance the implementation of ECS projects with lower costs and improved efficiency;The senior management of Camelot, including...

Mainz, Germany, August 2, 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter on Monday, August 9th, 2021. BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on the same day at 8.00 a.m. EDT (2.00 p.m. CEST) to report its financial results and provide a corporate update for the second quarter 2021. The slide presentation and audio of the webcast will be available via this link. To participate in the conference call, please dial the following numbers ten minutes prior to the start and provide the Conference ID:United States international: United States domestic (toll-free):Germany:Conference ID: +1 646 741 3167+1 877 870 9135+49 (0) 692 2222 6255378733Participants may...

NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) announced today that Prospect’s preferred stock offerings (collectively, the “Preferred Stock”) have exceeded $300 million in aggregate liquidation preference issuances since the initial closing in the quarter ending December 31, 2020. “Prospect’s Preferred Stock has been sold across institutional, registered investment advisor, wirehouse, and independent private wealth investor channels, with significant demand due to the Preferred Stock’s investor-friendly attributes that include credit support, liquidity, and income,” said Grier Eliasek, President of Prospect. On July 12, 2021, Prospect announced the pricing of an underwritten public offering of $150 million in aggregate liquidation...